GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Decipher Labs Ltd (BOM:524752) » Definitions » Equity-to-Asset

Decipher Labs (BOM:524752) Equity-to-Asset : 0.00 (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Decipher Labs Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Decipher Labs's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₹0.0 Mil. Decipher Labs's Total Assets for the quarter that ended in Dec. 2023 was ₹0.0 Mil.

The historical rank and industry rank for Decipher Labs's Equity-to-Asset or its related term are showing as below:

BOM:524752' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.25   Med: 0.72   Max: 0.92
Current: 0.86

During the past 13 years, the highest Equity to Asset Ratio of Decipher Labs was 0.92. The lowest was 0.25. And the median was 0.72.

BOM:524752's Equity-to-Asset is ranked better than
89.23% of 1086 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs BOM:524752: 0.86

Decipher Labs Equity-to-Asset Historical Data

The historical data trend for Decipher Labs's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Decipher Labs Equity-to-Asset Chart

Decipher Labs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 0.36 0.35 0.58 0.82

Decipher Labs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.82 - 0.86 -

Competitive Comparison of Decipher Labs's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Decipher Labs's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Decipher Labs's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Decipher Labs's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Decipher Labs's Equity-to-Asset falls into.



Decipher Labs Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Decipher Labs's Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Equity to Asset (A: Mar. 2023 )=Total Stockholders Equity/Total Assets
=232.085/281.646
=0.82

Decipher Labs's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=0/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Decipher Labs  (BOM:524752) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Decipher Labs Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Decipher Labs's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Decipher Labs (BOM:524752) Business Description

Traded in Other Exchanges
N/A
Address
Road No. 2, 4th Floor, Plot No. 94, Sagar Society, Banjara Hills, Hyderabad, TG, IND, 500034
Decipher Labs Ltd, formerly Combat Drugs Ltd is an India-based company engaged in the trading and manufacturing of Pharmaceutical drugs. It also undertakes contract manufacturing services business. The group generates revenue from the sale of its pharmaceutical products.

Decipher Labs (BOM:524752) Headlines

No Headlines